Rubric Capital Management LP Sio Gene Therapies Inc. Transaction History

Rubric Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.28 - $0.41 $276,918 - $405,487	988,995 Added 16.45%	7,000,000 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$0.25 - $0.73 $752,751 - $2.2 Million	3,011,005 Added 100.37%	6,011,005 $2.17 Million
Q2 2021 Aug 13, 2021	BUY	$2.07 - $2.89 $1.03 Million - $1.44 Million	499,582 Added 19.98%	3,000,000 $8.19 Million
Q1 2021 May 14, 2021	BUY	$2.34 - $3.44 $386,610 - $568,349	165,218 Added 7.08%	2,500,418 $6.53 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $4.46 Million - $13.1 Million	2,335,200 New	2,335,200 $6.49 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.